Daniel Tardiff, Chief Scientific Officer at Camp4 Therapeutics Corp (CAMP), sold 1,738 shares at $4.76 ($8K) on 2026-08-19, disclosed to the SEC on 2026-08-19.
Open-market sale of $8k CAMP by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.